netFormulary NHS
Demonstration Formulary
 Search
 Results

Looking for Dapagliflozin found 12 matches
Open monograph to display formulary status BNF Category
  Dapagliflozin Endocrine system - SGL2 inhibitors - 06.01.02.03
  Dapagliflozin / Metformin  (Xigduo®) Endocrine system - Other antidiabetic drugs - 06.01.02.03
 
Non Formulary BNF Category
  Saxagliptin and Dapagliflozin Endocrine system - Other antidiabetic drugs - 06.01.02.03


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA: SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): risk of diabetic ketoacidosis (06.01.02.03)
link in drug section MHRA: SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): risk of diabetic ketoacidosis (06.01.02.03)
link in drug section NICE TA288: Dapagliflozin in combination therapy for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA418: Dapagliflozin in triple therapy for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA679: Dapagliflozin for treating chronic heart failure with reduced ejection fraction (06.01.02.03)
link in drug section NICE TA775: Dapagliflozin for treating chronic kidney disease (06.01.02.03)


 
netFormulary